Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-10Clinical Trial Update: The Effect of Beta-glucan in Non-Small Cell Lung Cancer [NA]
A clinical trial evaluating beta-glucan in non-small cell lung cancer is currently recruiting, sponsored by the University of Louisville.
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: QYJD Compound Preparation Promotes Rapid Postoperative Recovery in Early-stage NSCLC Patients by Regulating Tissue Microecology: a Prospective, Randomized Controlled, Open-label, Phase I Clinical Study With Predefined Future Exploration [Phase 1]
A Phase 1 randomized, open-label trial evaluating QYJD Compound Preparation for improving postoperative recovery in early-stage non-small ce…
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: Ivonescimab Combined With Chemotherapy for the Treatment of Leptomeningeal Metastases Failed to EGFR-TKIs [NA]
Clinical trial update indicates Ivonescimab (AK112) combined with chemotherapy for leptomeningeal metastasis in non-small cell lung cancer a…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS [Phase 1, Phase 2]
This Clinical Trials update describes a Phase 1/Phase 2 trial evaluating intratumoral injection of IP-001 following thermal ablation in pati…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC
This clinical study investigates molecular residual disease, dynamic monitoring, and recurrence in Stage III driver-mutated non-small cell l…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy [Phase 1]
Phase 1 clinical trial update for QL-1706 antibodies combined with pulsed low dose rate external irradiation (PLDR) in patients with cancers…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents [Phase 1, Phase 2]
Clinical trial update for OR502, a monoclonal antibody targeting LILRB2, studied alone and with anticancer agents in Phase 1/2; recruitment …
-
CLINICAL_TRIALS research · 2025-01-06Clinical Trial Update: FHND9041 Versus Afatinib for Non-small Cell Lung Cancer [Phase 3]
A Phase 3 trial comparing FHND9041 to Afatinib for non-small cell lung cancer is currently enrolling by invitation.
-
CLINICAL_TRIALS research · 2025-01-06Clinical Trial Update: Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-advanced EGFR Mutation-positive Non-Small Cell Lung Cancer [Phase 2]
Phase 2 neoadjuvant trial evaluating befotertinib plus bevacizumab or platinum-based chemotherapy for resectable locally-advanced EGFR-mutan…
-
CLINICAL_TRIALS research · 2025-01-06Clinical Trial Update: Feasibility of Primer Shot Radiotherapy for Non-small Cell Lung Cancer - PRIMER [NA]
This document describes the PRIMER study on the feasibility of primer-shot radiotherapy for non-small cell lung cancer, currently in recruit…
-
CLINICAL_TRIALS research · 2025-01-03Clinical Trial Update: A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for HB0036 in adults with advanced solid tumors, including non-small cell lung cancer, focusing on safety …
-
CLINICAL_TRIALS research · 2025-01-03Clinical Trial Update: Cryobiopsy Vs. Forceps Biopsy for Peripheral Pulmonary Lesions [NA]
A clinical trial comparing cryobiopsy to forceps biopsy for peripheral pulmonary lesions in non-small cell lung cancer patients, currently e…
-
CLINICAL_TRIALS research · 2025-01-03Clinical Trial Update: A Study on the Efficacy of Immunotherapy, the Occurrence and Severity of Adverse Reactions in Patients with Non-small Cell Lung Cancer in High-altitude Areas
This document reports a clinical trial investigating the efficacy of immunotherapy and the occurrence and severity of adverse reactions in p…
-
CLINICAL_TRIALS research · 2024-12-30Clinical Trial Update: Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment [Phase 2]
Phase 2 trial evaluating a neoantigen-loaded dendritic cell vaccine in combination with a PD-1 inhibitor and radiotherapy for advanced non-s…
-
CLINICAL_TRIALS research · 2024-12-30Clinical Trial Update: Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment [NA]
This clinical trial investigates a combination therapy for advanced non-small cell lung cancer involving a neoantigen-loaded dendritic cell …
-
CLINICAL_TRIALS research · 2024-12-30Clinical Trial Update: Aumolertinib Versus Osimertinib As First-line Therapy for Patients with EGFR Mutated Locally Advanced or Metastatic Non-small-cell Lung Cancer [Phase 2]
Phase 2 trial comparing Aumolertinib to Osimertinib as first-line therapy for EGFR-mutated locally advanced or metastatic non-small cell lun…
-
CLINICAL_TRIALS research · 2024-12-30Clinical Trial Update: Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment [NA]
A study evaluating a combination of a neoantigen-based peptide vaccine, a PD-1 inhibitor, and radiotherapy for advanced non-small cell lung …
-
CLINICAL_TRIALS research · 2024-12-30Clinical Trial Update: Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment [Phase 2]
Phase 2 clinical trial evaluating a neoantigen-based peptide vaccine in combination with a PD-1 inhibitor and radiotherapy for advanced non-…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Disitamab Vedotin in Combination with Tislelizumab and Bevacizumab in a Phase II Clinical Study of Locally Advanced or Metastatic Non-small Cell Lung Cancer with HER2 Mutation/amplification/expression [Phase 2]
Clinical trial update announcing a Phase II study of Disitamab Vedotin in combination with Tislelizumab and Bevacizumab for locally advanced…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: An Exploratory Study of Tislelizumab in Combination with Chemotherapy in Immuno-experienced Patients with EGFR/ALK/ROS1-negative Advanced NSCLC in the Second-line Setting [Phase 2]
This is a Phase 2 exploratory study evaluating tislelizumab in combination with chemotherapy for immuno-experienced patients with EGFR/ALK/R…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Impact of Concomitant Use of Steroids and Immune-Checkpoint Inhibitors on Survival Outcomes in NSCLC Patients
This clinical trial update discusses how the concurrent use of steroids with immune-checkpoint inhibitors may influence survival outcomes in…
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: A Phase II Clinical Study to Evaluate the Safety, Pharmacokinetic Profile, and Preliminary Efficacy of IMM2510 in Combination with Chemotherapy As First-line Treatment in Subjects with Non-small Cell Lung Cancer or Triple-negative Breast Cancer [Phase 2]
Phase II clinical study to evaluate safety, pharmacokinetics, and preliminary efficacy of IMM2510 in combination with chemotherapy as first-…
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: Neoadjuvant/Adjuvant Cadonilimab Plus Chemotherapy in Patients With Resectable PD-L1 Negative NSCLC [Phase 2]
A Phase 2 clinical trial is investigating neoadjuvant/adjuvant cadonilimab plus chemotherapy in patients with resectable PD-L1 negative non-…
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: FMT+Immunotherapy+Chemotherapy As First-line Treatment for Driver-gene Negative Advanced NSCLC [Phase 2]
A Phase 2 clinical trial evaluating fecal microbiota transplantation combined with immunotherapy and chemotherapy as first-line treatment fo…
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: Surgery After Verifying Existing Disease in Locally Advanced Operable Lung Cancer: A Pilot Study [Phase 1]
A Phase 1 pilot trial assesses performing surgery after confirming existing disease in locally advanced operable non-small cell lung cancer.…